An Instagram reel claims that Nicotine cures glioblastoma tumors in less than 72 hours. The claim by the user is ...

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with ...

Early results show that the combination of VXM01 plus avelumab demonstrated tolerable safety in recurrent glioblastoma.

PATIENT Richard Walker is celebrating reaching a landmark five per cent survival rate - following a diagnosis of a Glioblastoma 4 terminal ...

Patients living with glioblastoma, a rare cancer of the brain are calling on the province to provide coverage for Novocure’s ...

A hospital is upgrading its brain surgery unit with a £100,000 investment in new technology for neurosurgeons to perform more ...

Shares of OSR Holdings more than doubled after the company's Vaximm subsidiary announced final data from its Phase 2a clinical trial of VXM01 with avelumab, a drug combination aimed at treating ...

Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative ...